Search Results 401-410 of 2434 for 2024embarking
ROCHESTER, Minn. — Researchers from the Mayo Clinic Comprehensive Cancer Center are set to present key research findings, including two late-breaking abstracts, ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
The purpose of this study is to study the handling of ovarian tissue, cryopreservation technology, and oocyte maturation for female pediatric cancer ...
Mayo Clinic researchers made significant strides in 2025 toward predicting, preventing and treating some of the world's most serious and complex diseases.
This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...
ROCHESTER, Minn. — A new study published by Mayo Clinic researchers suggests that ovarian cancer cells quickly activate a survival response after PARP ...
About this study. The purpose of this study is to evaluate efficacy of the study drug on fatigue symptoms, impacts on daily living, lower extremity strength ...
Caspofungin acetate, fluconazole, and voriconazole may be effective in preventing fungal infections in patients following donor stem cell transplant. It is not ...
To assess the safety and feasibility of mesenchymal stem cells therapy in patients with transplant related bronchiolitis obliteran syndrome (BOS). Participation ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.